The benefits of SIRT1 have also been described in bone tissue, given its ability to reduce the expression of sclerostin, the primary negative regulator of bone growth [21], suppress osteoclastogenesis [22], and reduce age-related cartilage degeneration, representing a potential therapeutic target to counter osteoporosis and osteoarthritis [13,23]. Here, SIRT1 is linked to osteoporosis.